×
About 2,498 results

ALLMedicine™ Hypopituitarism Center

Research & Reviews  890 results

Intrasellar pressure is related to endocrine disturbances in patients with pituitary tu...
https://doi.org/10.1016/j.wneu.2023.03.085
World Neurosurgery; Simander G, Dahlqvist P et. al.

Mar 27th, 2023 - To investigate the association between intraoperative intrasellar pressure (ISP) and pre- and postoperative endocrine disturbances with focus on hyperprolactinemia and hypopituitarism in patients with pituitary tumours. The study is a consecutive,...

Molecular Imaging of Pituitary Tumors.
https://doi.org/10.1053/j.semnuclmed.2023.02.005
Seminars in Nuclear Medicine; Gillett D, MacFarlane J et. al.

Mar 26th, 2023 - Tumors of the pituitary gland, although mostly benign adenomas, are a cause of significant morbidity and even excess mortality due to local compressive effects (eg visual loss, hypopituitarism) and unregulated hormone secretion (eg acromegaly or C...

Intrasellar xanthogranuloma mimicking macroadenoma.
https://doi.org/10.1177/19714009231166075
The Neuroradiology Journal; Tartuci IT, Junior NADS et. al.

Mar 24th, 2023 - Intracranial xanthogranulomas (XGs) have been found at various sites, but xanthogranuloma of the sellar region is extremely rare. We report about a case of sellar XG in a 34-year-old female. Magnetic resonance imaging showed a solid-cystic mass lo...

Pituitary and SARS CoV-2: An unremitting conundrum.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969757
Best Practice & Research. Clinical Endocrinology & Metabo... Capatina C, Poiana C et. al.

Mar 7th, 2023 - There is increased interest related to the impact of coronavirus disease 19 (COVID-19) on the endocrine system and in particular on the pituitary gland. Over the course of the severe infection with acute respiratory syndrome coronavirus 2 (SARS-Co...

One Case of Pituitary Stalk Interruption Syndrome associated with Liver Cirrhosis.
https://doi.org/10.2174/1871530323666230228110650
Endocrine, Metabolic & Immune Disorders Drug Targets; He H, Li DM

Mar 1st, 2023 - Pituitary stalk interruption syndrome (PSIS) is featured by hypopituitarism and a classic triad of absence or slender pituitary stalk, absence or ectopic posterior lobe, and hypoplasia of the anterior lobe. Hypopituitarism, which induces hormone d...

see more →

Guidelines  5 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practi...
https://doi.org/10.1210/jc.2016-2118
The Journal of Clinical Endocrinology and Metabolism; Fleseriu M, Hashim IA et. al.

Nov 5th, 2016 - To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pr...
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pri...
https://doi.org/10.1227/NEU.0000000000001389
Neurosurgery Lucas JW, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present clinically with vision loss and hypopituitarism. To characterize the existing literature as it pertains to the initial management of NFPAs. A sys...

Pituitary incidentaloma: an endocrine society clinical practice guideline.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393422
The Journal of Clinical Endocrinology and Metabolism; Freda PU, Beckers AM et. al.

Apr 9th, 2011 - The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in-per...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  34 results

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine Immune-related Adverse Events (irAEs)
https://clinicaltrials.gov/ct2/show/NCT05675111

Jan 9th, 2023 - Immune checkpoint inhibitor (ICI) includes agents that block cytotoxic T-cell-associated antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), and programmed cell death protein ligand 1 (PD-L1). Since the FDA-approval of the CTLA-4 inhibitor...

Growth Hormone Deficiency in Mild Traumatic Brain Injury
https://clinicaltrials.gov/ct2/show/NCT05660356

Dec 21st, 2022 - Annually, over 250,000 Canadians and over 40 million individuals worldwide will suffer an uncomplicated concussion (head injury with no intracranial abnormalities seen on imaging). Most individuals will recover within weeks of injury but over 30% ...

Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
https://clinicaltrials.gov/ct2/show/NCT05403255

Jun 3rd, 2022 - Objectives: Describe the quality of life and psychosocial repercussions of the disease in children 10-17 years of age with multiple pituitary hormone deficiency (either acquired or congenital), or isolated pituitary hormone deficiency (other than ...

Treatment of Adrenal Insufficiency in Children
https://clinicaltrials.gov/ct2/show/NCT02720952

May 4th, 2022 - This is a Phase 3, open label, single centre study of Infacort® in neonates, infants and children less than 6 years of age with adrenal insufficiency. The study will be conducted in a total of 24 subjects, before their 6th birthday, requiring repl...

Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls
https://clinicaltrials.gov/ct2/show/NCT04648137

Apr 13th, 2022 - Disruption of the hypothalamic-pituitary axis due to congenital abnormalities, tumors or head trauma may cause anterior and/or posterior pituitary deficiency also known as partial or panhypopituitarism. Patients with hypopituitarism, especially th...

see more →

News  57 results

Long COVID Case Study: Persistent Hormone Deficiencies
https://www.medscape.com/viewarticle/979314

Aug 17th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A case study of a 65-year-old man in Japan with long COVID describes how he recovered from certain impaired hormone deficiencies that persisted fo...

Breast Cancer Treatment Advances Lead to Broadened Scope of Personalized Medicine
https://www.onclive.com/view/breast-cancer-treatment-advances-lead-to-broadened-scope-of-personalized-medicine

Mar 21st, 2022 - As a result of many positive trials throughout breast cancer in recent years, the treatment armamentarium has blossomed with CDK4/6 inhibitors, checkpoint inhibitors, and antibody-drug conjugates (ADCs) to name a few, explained Harold J. Burstein,...

Switching Levothyroxine Generics Doesn't Affect TSH Levels, Study Finds
https://www.medpagetoday.com/endocrinology/thyroid/97418

Feb 28th, 2022 - Switching between generic levothyroxine products won't make much of a clinical difference, a new study suggested. In a comparative effectiveness research study of 15,829 patients, those who switched up their generic levothyroxine product didn't se...

Multidisciplinary Care for Malignant Melanoma
https://www.onclive.com/view/multidisciplinary-care-for-malignant-melanoma

Apr 2nd, 2021 - For High-Definition, Click The treatment of patients with metastatic melanoma requires a team approach. The complexities of this disease warrants impute from several specialists to properly deliver care, the panelists agree. Along these lines, h...

I/O Second-Line Treatment
https://www.onclive.com/view/i-o-second-line-treatment

Apr 2nd, 2021 - Peter Galle, MD: What do we have as evidence? The only I/O agent that has been convincing in demonstrating benefit was atezolizumab in combination with bevacizumab in first line. That’s what we have. The monotherapy has not made it into a signific...

see more →

Patient Education  11 results see all →